New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
16:17 EDTAEZSAeterna Zentaris announces at the market issuance program
Aeterna Zentaris announced that it has entered into an at the market issuance sales agreement with MLV & Co. under which the company may, at its discretion, from time to time during the term of the sales agreement, sell up to a maximum of 14.02M of its common shares through ATM issuances up to an aggregate amount of $15M. MLV will act as sales agent for any sales made under the ATM. The common shares will be sold at market prices prevailing at the time of the sale of common shares, and, as a result, prices may vary.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
07:34 EDTAEZSAeterna Zentaris adds center to Phase 3 trial in endometrial cancer
Aeterna Zentaris announced the opening of a new clinical site at the Hollings Cancer Center of the Medical University of South Carolina in Charleston, South Carolina, for the company's ongoing multinational, pivotal ZoptEC Phase 3 trial in women with advanced, recurrent or metastatic endometrial cancer. Furthermore, the company announced that patient recruitment for this trial now stands at over 320 patients out of a projected total of 500 patients. Patient recruitment is in line to secure expected interim analysis in H1 2015, the company said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use